MCL Featured Stories
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the future of diagnostics. Later, Eric Hsi, M.D., chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology in Rochester, shares how the department is advancing innovation and helping transform healthcare through laboratory medicine.
REGISTER NOW - This presentation examines how autonomous robotic phlebotomy could transform blood collection. It reviews preanalytic challenges, high-opportunity use cases, clinical findings, and Mayo Clinic human-factors research, with a focus on specimen quality, patient acceptance, workflow, workforce models, and human oversight.
A glossary of essential reimbursement terms to help laboratories improve claims, understand coverage, and forecast revenue.
Building on decades of leadership in autoimmune dysautonomia research, Mayo Clinic Laboratories has enhanced its dysautonomia antibody evaluation with a more sensitive, live cell-based flow cytometry method. The streamlined panel focuses on clinically relevant autoantibodies, providing physicians with actionable insights for diagnosis, prognosis, and treatment planning.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Mayo Clinic’s new collaboration with Thermo Fisher and the latest on the Protecting Access to Medicare Act (PAMA). Later, Dr. Pritt welcomes Matt Binnicker, Ph.D., Mayo Clinic Laboratories’ chief scientific officer and a leader in novel diagnostics for viral infections, to explore seasonal virus activity.
Review how problem-solving methods can work together to define and measure a problem, identify root causes, test potential solutions, and sustain successful improvements.
This microlearning reviews myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), with a focus on the 2023 International MOGAD Panel diagnostic criteria.
Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medicine across Southeast Asia, Australia and New Zealand.
Learn more about how Mayo Clinic Laboratories first-in-class insulin analogs assay uses liquid chromatography-high resolution mass spectrometry to provide clinicians with a highly specific way to identify and differentiate human insulin from multiple synthetic insulin analogs from a single blood sample. By overcoming the limitations of traditional immunoassays, the test delivers greater diagnostic clarity in complex hypoglycemia cases, helping clinicians reach accurate diagnoses faster and guide more effective patient care.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.
Specialized immunofluorescence testing helps uncover rare autoimmune blistering diseases, identify underlying cancers, and guide precise treatment, improving diagnostic accuracy and outcomes for patients with challenging skin disorders.
Join Mayo Clinic Laboratories and C2N Diagnostics for our webinar exploring how the evolution of blood biomarker testing for Alzheimer's disease has expanded access to earlier, less-invasive diagnosis. Focusing on the newly FDA-cleared PrecivityAD2 blood test, which is offered by Mayo Clinic Laboratories in collaboration with C2N Diagnostics, the discussion will highlight how results from blood biomarker testing can support timely diagnosis, informed clinical decision-making, and improved patient care.
Collaborating with Mayo Clinic Laboratories, UNC Health streamlined neuroimmunology test ordering — eliminating outmoded testing and elevating diagnostic accuracy.